Oosterlynck, Marie
Fichter, Laura
Leroux, Elodie
Eddarkaoui, Sabiha
Bouillet, Thomas
Lefebvre, Camille
Nguyen, Marine
Maurage, Claude-Alain
Accart, Bertrand
Dupré, Elian
Landrieu, Isabelle
Danis, Clément
Lehmann, Sylvain
Vialaret, Jérôme https://orcid.org/0000-0002-3730-2366
Buée, Luc https://orcid.org/0000-0002-6261-4230
Hirtz, Christophe https://orcid.org/0000-0002-7313-0629
Colin, Morvane https://orcid.org/0000-0003-0611-4167
Funding for this research was provided by:
ANR, France, ToNIC (18-CE44-0016)
LabEx DISTALZ
LiCEND
Métropole Européenne de Lille
Région Hauts de France
European Union (HORIZON-MSCA-2022-DN-01)
Rainwater Charitable Foundation & Alzheimer’s Association (T-PEP-23-969176)
ANR, France, NanoTarget (22-CE92-0061)
ANR, France, Tauseed (21-CE18-0046)
France Alzheimer (AAPSM2020#3056)
ANR, France (24-INBS-0015)
Article History
Received: 25 August 2025
Accepted: 27 April 2026
First Online: 15 June 2026
Declarations
:
: The study was performed in accordance with French and European Community rules. The experimental research was performed with the approval of an ethics committee (agreement APAFIS #32893-2022011812168639 v5) and follows European guidelines for the use of animals.G, Babić Leko M, Wray S, Harrington
: C.D., E.D., L.B., and I.L. are the inventors of a patent (WO2020/120644A1) that covers the use of VHH Z70 and VHHs derived from it. The remaining authors declare no competing interests.